Award
Delivery Order #SPE2DR26FXYF0
AmerisourceBergen Delivery Order for Ondansetron Tablets under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$1,305.85
Ceiling
$1,305.85
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FXYF0
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, as part of an existing indefinite delivery vehicle (IDV) contract focused on pharmaceutical services. The order procures Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. This delivery order is significant as it supports the agency's ongoing pharmaceutical supply chain needs, ensuring the timely availability of critical medications for healthcare purposes. The scope involves the procurement and delivery of the specified medication within a short timeframe, reflecting agile support for medical treatment regimens. Awarded through the established IDV, this order benefits from streamlined acquisition processes, enhancing efficiency and responsiveness. The delivery period is brief and specific, occurring over a few days, which underlines its role in meeting immediate pharmaceutical demands. This award exemplifies the continuing partnership between the agency and AmerisourceBergen to maintain essential healthcare supplies.
Description
4570902299!ONDANSETRON HCL 8 MG TABLET 30S